GLP‐1 agonists vs placebo
Serious adverse events · adults with Parkinson's disease
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
It is very uncertain whether GLP‐1 receptor agonists changes serious adverse events. compared with no treatment (very low certainty).